Log in

Mesa Laboratories Stock Price, News & Analysis (NASDAQ:MLAB)

$213.21
-4.37 (-2.01 %)
(As of 10/18/2019 04:00 PM ET)
Today's Range
$210.01
Now: $213.21
$218.00
50-Day Range
$210.93
MA: $228.52
$252.81
52-Week Range
$169.80
Now: $213.21
$268.47
Volume43,226 shs
Average Volume43,084 shs
Market Capitalization$929.60 million
P/E Ratio39.70
Dividend Yield0.29%
Beta0.26
Mesa Laboratories, Inc designs, manufactures, and markets quality control instruments and disposable products. The company's Instruments segment offers data loggers, which are precision instruments used in critical manufacturing, quality control, and validation applications; medical meters and calibration solutions used to test various parameters of the dialysis fluid, and the calibration and operation of the dialysis machine; gas flow calibration and air sampling equipment that are used for industrial hygiene assessments, calibration of gas metering equipment, and environmental air monitoring; and torque testing systems used for measure bottle cap tightness. Read More…

Industry, Sector and Symbol

Industry Process control instruments
Sub-IndustryElectronic Equipment & Instruments
SectorMedical
Current SymbolNASDAQ:MLAB
CUSIP59064R10
Phone303-987-8000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$103.14 million
Cash Flow$7.87 per share
Book Value$28.77 per share

Profitability

Net Income$7.48 million

Miscellaneous

Employees366
Market Cap$929.60 million
Next Earnings Date10/30/2019 (Estimated)
OptionableNot Optionable

Receive MLAB News and Ratings via Email

Sign-up to receive the latest news and ratings for MLAB and its competitors with MarketBeat's FREE daily newsletter.


Mesa Laboratories (NASDAQ:MLAB) Frequently Asked Questions

What is Mesa Laboratories' stock symbol?

Mesa Laboratories trades on the NASDAQ under the ticker symbol "MLAB."

How often does Mesa Laboratories pay dividends? What is the dividend yield for Mesa Laboratories?

Mesa Laboratories declared a quarterly dividend on Tuesday, October 1st. Shareholders of record on Friday, November 29th will be given a dividend of $0.16 per share on Monday, December 16th. This represents a $0.64 dividend on an annualized basis and a yield of 0.30%. The ex-dividend date is Wednesday, November 27th. View Mesa Laboratories' Dividend History.

How were Mesa Laboratories' earnings last quarter?

Mesa Laboratories, Inc. (NASDAQ:MLAB) released its quarterly earnings results on Tuesday, July, 30th. The medical instruments supplier reported $1.73 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $1.59 by $0.14. The medical instruments supplier earned $26.29 million during the quarter, compared to analysts' expectations of $25.70 million. Mesa Laboratories had a net margin of 7.53% and a return on equity of 19.67%. View Mesa Laboratories' Earnings History.

When is Mesa Laboratories' next earnings date?

Mesa Laboratories is scheduled to release their next quarterly earnings announcement on Wednesday, October 30th 2019. View Earnings Estimates for Mesa Laboratories.

What price target have analysts set for MLAB?

2 brokerages have issued 12-month price objectives for Mesa Laboratories' shares. Their predictions range from $250.00 to $250.00. On average, they anticipate Mesa Laboratories' share price to reach $250.00 in the next year. This suggests a possible upside of 17.3% from the stock's current price. View Analyst Price Targets for Mesa Laboratories.

What is the consensus analysts' recommendation for Mesa Laboratories?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Mesa Laboratories in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Mesa Laboratories.

Has Mesa Laboratories been receiving favorable news coverage?

News coverage about MLAB stock has trended somewhat positive this week, InfoTrie Sentiment reports. InfoTrie identifies negative and positive news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Mesa Laboratories earned a news impact score of 0.8 on InfoTrie's scale. They also gave news articles about the medical instruments supplier a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for Mesa Laboratories.

Who are some of Mesa Laboratories' key competitors?

What other stocks do shareholders of Mesa Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Mesa Laboratories investors own include NVIDIA (NVDA), Intel (INTC), Micron Technology (MU), Verizon Communications (VZ), Coupa Software (COUP), PepsiCo (PEP), Alibaba Group (BABA), Becton Dickinson and (BDX), Appian (APPN) and Crispr Therapeutics (CRSP).

Who are Mesa Laboratories' key executives?

Mesa Laboratories' management team includes the folowing people:
  • Mr. Gary M. Owens, CEO, Pres & Director (Age 51)
  • Mr. John V. Sakys, Chief Financial Officer, Chief Accounting Officer, Sec. & Treasurer (Age 50)
  • Mr. Gregory T. DiNoia, Sr. VP of Commercial Operations (Age 54)
  • Ms. Helene R. Leone, Gen. Counsel
  • Mr. Peter Jung, VP of Corp. Devel. & Strategy

Who are Mesa Laboratories' major shareholders?

Mesa Laboratories' stock is owned by a variety of of institutional and retail investors. Top institutional investors include Envestnet Asset Management Inc. (0.09%), State of Alaska Department of Revenue (0.07%), Navellier & Associates Inc (0.03%), Kistler Tiffany Companies LLC (0.03%), NEXT Financial Group Inc (0.03%) and Zurcher Kantonalbank Zurich Cantonalbank (0.00%). Company insiders that own Mesa Laboratories stock include David M Kelly, Evan Guillemin, H Stuart Campbell, John Bradley Schmieder, John James Sullivan, John Sakys, Michael T Brooks, Robert V Dwyer and Seg Ventures, Llc. View Institutional Ownership Trends for Mesa Laboratories.

Which institutional investors are selling Mesa Laboratories stock?

MLAB stock was sold by a variety of institutional investors in the last quarter, including Kistler Tiffany Companies LLC, Navellier & Associates Inc and NEXT Financial Group Inc. Company insiders that have sold Mesa Laboratories company stock in the last year include David M Kelly, Evan Guillemin, John Bradley Schmieder and Robert V Dwyer. View Insider Buying and Selling for Mesa Laboratories.

Which institutional investors are buying Mesa Laboratories stock?

MLAB stock was bought by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, Envestnet Asset Management Inc. and Zurcher Kantonalbank Zurich Cantonalbank . View Insider Buying and Selling for Mesa Laboratories.

How do I buy shares of Mesa Laboratories?

Shares of MLAB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Mesa Laboratories' stock price today?

One share of MLAB stock can currently be purchased for approximately $213.21.

How big of a company is Mesa Laboratories?

Mesa Laboratories has a market capitalization of $929.60 million and generates $103.14 million in revenue each year. The medical instruments supplier earns $7.48 million in net income (profit) each year or $5.37 on an earnings per share basis. Mesa Laboratories employs 366 workers across the globe.View Additional Information About Mesa Laboratories.

What is Mesa Laboratories' official website?

The official website for Mesa Laboratories is http://www.mesalabs.com/.

How can I contact Mesa Laboratories?

Mesa Laboratories' mailing address is 12100 W 6TH AVE, LAKEWOOD CO, 80228. The medical instruments supplier can be reached via phone at 303-987-8000 or via email at [email protected]


MarketBeat Community Rating for Mesa Laboratories (NASDAQ MLAB)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  188 (Vote Outperform)
Underperform Votes:  171 (Vote Underperform)
Total Votes:  359
MarketBeat's community ratings are surveys of what our community members think about Mesa Laboratories and other stocks. Vote "Outperform" if you believe MLAB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MLAB will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel